4.4 Review

Cancer stem cells in breast: Current opinion and future challenges

Journal

PATHOBIOLOGY
Volume 75, Issue 2, Pages 75-84

Publisher

KARGER
DOI: 10.1159/000123845

Keywords

breast cancer; stem cell; targeted therapy; aldehyde dehydrogenase

Funding

  1. NCI NIH HHS [R01 CA129765-02, R01 CA129765] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA129765] Funding Source: NIH RePORTER

Ask authors/readers for more resources

There is increasing evidence for the cancer stem cell hypothesis, which holds that cancers are driven by a cellular sub-component that has stem cell properties, that is, self-renewal, tumorigenicity and multilineage differentiation capacity. The cancer stem cell hypothesis modifies our conceptual approach of oncogenesis and shall have implications in breast cancer prevention, detection and treatment, especially in metastatic breast cancer for which no curative treatment exists. Given the specific stem cell features, novel therapeutic pathways can be targeted. Following this approach, new molecules are currently in development. Focusing on the cross-talk between stem cells and their microenvironment is also a promising way to explore how to better target cancer stem cells and be curative. Copyright (c) 2008 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available